ClinicalTrials.gg
CompletedNCT07912762Updated Nov 3, 2026

The Immediate Effect of Motor Imagery on Functional Upper Limb Movement in Stroke Survivors Assessed Using Surface Electromyography and Kinematic Analysis

An interventional study of motor imagery and non-motor imagery in Motor Imagery, Stroke and Surface Electromyography, sponsored by Miroslav Haltmar. Completed at 1 site in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Miroslav Haltmar · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 4 years 9 months after the study started (first participant enrolled Jan 2022, registered Oct 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The study aims to evaluate the immediate effect of motor imagery on functional upper limb movement in stroke survivors using surface electromyography and kinematic analysis.

02

Conditions studied

  • Motor Imagery
  • Stroke
  • Surface Electromyography
  • Kinematics

Browse trials for

03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 56 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

This is the only study on the registry with Miroslav Haltmar as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • first episode of ischemic stroke
  • subacute stage of stroke (less than 3 months)
  • mild to moderate upper limb hemiparesis
  • absence of cognitive deficit and ability to understand research tasks
  • adequate motor or mental imagery performance

Exclusion criteria

Exclusion Criteria:

  • history of multiple strokes
  • time since stroke of more than 3 months
  • cognitive impairment, including aphasia, limiting the ability to understand research tasks
  • psychiatric disorders
  • obesity ( greater than 40)
  • diagnosed or treated cancer
  • severe coronary artery disease
  • presence of orthopedic or neurological conditions affecting the upper limb
  • other severe internal medical conditions that may affect the patient's quality of life
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    experimental group

    motor imagery group

    Behavioral: motor imagery

  • Other
    control group

    non-motor imagery group

    Behavioral: non-motor imagery

Interventions

  • Behavioralmotor imagery

    motor imagery of functional upper limb movement

  • Behavioralnon-motor imagery

    mental imagery of singing the song "Happy Birthday"

06

What researchers measure

Primary outcomes

  1. Objective measurement of muscle activity

    Muscle activity \[V\] was measured using surface electromyography during actual movement before and after the intervetion.

    Time frame: Day 1

  2. Objective measurement of upper arm kinematics

    Upper arm kinematics were assessed by gyroscope \[deg/s\] during actual movement before and after the intervention.

    Time frame: Day 1

07

Study locations

1 site
  • University Hospital Olomouc
    Olomouc, 77900, Czechia
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2022 to primary completion in Jun 2024, 28 months.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 28 months is above that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2026
First posted
Nov 3, 2026
StartActual
Jan 21, 2022
Primary completionActual
Jun 13, 2024
CompletionActual
Jun 13, 2024
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07912762
Lead sponsor
Miroslav Haltmar
Responsible party
Miroslav Haltmar (PhD student, Palacky University) — Sponsor-investigator
First posted
Nov 3, 2026
Start date
Jan 21, 2022
Primary completion
Jun 13, 2024
Completion
Jun 13, 2024
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion